GlobeNewswire

REPURCHASE OF SHARES

Share

REPURCHASE OF SHARES

Amsterdam, the Netherlands - Flow Traders N.V. (“Flow Traders”) (Euronext: FLOW) has successfully completed its share buyback programme.

Flow Traders purchased 8,903 of its own shares on 15 April 2021 at an average price of €37.22 in accordance with the share buyback programme announced on 12 February 2021. These repurchases were made in order to satisfy the requirements of various employee incentive plans. The consideration of this purchase was €0.3 million. The total number of shares purchased under this programme is 725,577 shares at an average price of €34.45 for a total consideration of €25.0 million.

2,285,243 shares were held in treasury as at 15 April 2021.

Contact Details

Flow Traders N.V.
Jonathan Berger / Investor Relations Officer
Phone:   +31 20 7996799
Email:     investor.relations@flowtraders.com

About Flow Traders

Flow Traders is a leading global financial technology-enabled liquidity provider in financial products, historically specialized in Exchange Traded Products (ETPs), now expanding into other asset classes. Flow Traders ensures the provision of liquidity to support the uninterrupted functioning of financial markets. This allows investors to continue to buy or sell ETPs or other financial instruments under all market circumstances. We continuously grow our organization, ensuring that our trading desks in Europe, the Americas and Asia can provide liquidity across all major exchanges, globally, 24 hours a day. Founded in 2004, we continue to cultivate the entrepreneurial, innovative and team-oriented culture that has been with us since the beginning.


Important Legal Information

This press release is prepared by Flow Traders N.V. and is for information purposes only. It is not a recommendation to engage in investment activities and you must not rely on the content of this document when making any investment decisions. The information in this document does not constitute legal, tax, or investment advice and is not to be regarded as investor marketing or marketing of any security or financial instrument, or as an offer to buy or sell, or as a solicitation of any offer to buy or sell, securities or financial instruments.

The information and materials contained in this press release are provided ‘as is’ and Flow Traders N.V. or any of its affiliates (“Flow Traders”) do not warrant the accuracy, adequacy or completeness of the information and materials and expressly disclaim liability for any errors or omissions. This press release is not intended to be, and shall not constitute in any way a binding or legal agreement, or impose any legal obligation on Flow Traders. All intellectual property rights, including trademarks, are those of their respective owners. All rights reserved. All proprietary rights and interest in or connected with this publication shall vest in Flow Traders. No part of it may be redistributed or reproduced without the prior written permission of Flow Traders.

Flow Traders expressly disclaims any obligation or undertaking to update, review or revise any forward-looking statements contained in this press release to reflect any change in its expectations or any change in events, conditions or circumstances on which such statements are based unless required to do so by applicable law.

By accepting this document you agree to the terms set out above. If you do not agree with the terms set out above please notify legal.amsterdam@nl.flowtraders.com immediately and delete or destroy this document.

Market Abuse Regulation

This press release is an announcement pursuant to Article 5 (1) of the EU Market Abuse Regulation.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Leasinvest Real Estate intends to become an integrated real estate group through an envisaged business combination with Extensa Group and by giving up its BE-REIT status12.5.2021 19:13:09 CEST | Press release

JAN SUYKENS, CEO ACKERMANS & VAN HAAREN CHAIRMAN LEASINVEST RE: “AvH, which owns today both 30.01% of LRE and 100% of Extensa, is pleased to be able to support the evolution of the Company’s strategy as proposed by its management. Through the contribution of our stake in Extensa, we strengthen our commitment to LRE and we support the intended strategic evolution towards a mixed real estate investment and development group.” MICHEL VAN GEYTE, CEO LEASINVEST RE: “’Leasinvest 2.0’ will become a real estate player with a unique market position that combines the best of both worlds: recurring rental income from real estate investments and added value potential from development activities. In addition, ‘Leasinvest 2.0’ will operate from a thorough sustainability vision in which it will make a lasting contribution to the development and optimization of its real estate portfolio in Belgium, the Grand Duchy of Luxemburg and Austria.” A unique combination Leasinvest Real Estate (the “Company”) a

Volta Finance Limited - Net Asset Value as at 30 April 202112.5.2021 18:17:42 CEST | Press release

Volta Finance Limited (VTA / VTAS) –April2021 monthly report NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES ***** Guernsey, 12May2021 AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for April. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com). PERFORMANCE and PORTFOLIO ACTIVITY Volta has continued to perform well with +2.1% in April, reaching a total return of 8.4% for the first four months of 2021. In April, Volta paid €0.14 per share dividend to shareholders (circa 8% annualized yield), a €0.02 increase relative to the January dividend payment, evidencing the improving situation of Volta. This time around, the performance was driven almost evenly by the solid performance from CLO equity and CLO debt tranches. This month, contrary to March, the USD depreciation cost almost 1% of the monthly performance. The monthly

Idorsia holds its Annual General Meeting of Shareholders12.5.2021 18:09:53 CEST | Press release

Allschwil, Switzerland – May12, 2021 All Board proposals approved by the Shareholders At today’s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Allschwil, Switzerland, shareholders voted in favor of all proposals by the Board of Directors with a large majority. The meeting was held in accordance with the requirements of the COVID‑19 Ordinance 3, issued by the Swiss Federal Council. As a result, attendance in person was not possible and voting took place by independent proxy. In total, 4,541 shareholders voted through the independent proxy, representing a total of 112,170,657 shares, or 67.13% of the total outstanding shares. Mathieu Simon, MD, Chairman of the Board of Directors of Idorsia, commented: “Despite the global pandemic, Idorsia looks back on an incredibly successful year and the future promises to not lose any momentum. The coming year will be crucial as we continue to build the foundation of Idorsia's future. I am very proud to have been re-elected as your C

All resolutions adopted at AGM Beter Bed Holding N.V.12.5.2021 18:00:00 CEST | Press release

Beter Bed Holding N.V. (BBH) – a sleep specialist operating in the European retail, wholesale and B2B sectors – held its 2021 Annual General Meeting (AGM) in virtual form today. BBH is pleased to announce that all resolutions including the 2020 financial statements were adopted as proposed. When the resolutions were voted on, 11,577,389shares were represented, corresponding to 44.12 % of the 26,240,397 shares issued. The details of the voting results can be found atwww.beterbedholding.com. During the AGM, John Kruijssen, CEO, and Gabrielle Reijnen, CFO, also presented the strategic direction going forward, inspired by major global trends which will shape the future of the bedding industry. A separate press release on the strategy update was published this morning. The AGM presentation as well as the analyst presentation regarding the strategy update can be found on the BBH website at www.beterbedholding.com. About Beter Bed Holding Beter Bed Holding N.V. is a sleep specialist operating

OPENING OF NEW BRANCH OFFICE IN PARIS12.5.2021 17:45:00 CEST | Press release

OPENING OF NEW BRANCH OFFICE IN PARIS Amsterdam, the Netherlands – 12May 2021. Flow Traders N.V. (“Flow Traders”) announces the opening of new branch office in Paris, France. Today, Flow Traders announces the opening of a new branch office in Paris. The opening of this new branch office is consistent with Flow Traders’ growth strategy to deepen its global footprint and it will enable Flow Traders to have a physical presence in another key EMEA market. This office, alongside those in Amsterdam, London and Milan, will together cover the EMEA region for Flow Traders. Flow Traders’ day-to-day operations in Paris will be headed by Pierre-Antoine Jaunatre. The branch office will report directly into Flow Traders B.V.’s Amsterdam office. Ron Heydenrijk, European Head of Sales and External Relations, stated: “Following the successful opening of our London and Milan branches in 2018 and 2020, we are extremely pleased to be opening a third European branch office in Paris. Flow Traders’ continued

Immunicum håller presentationer vid European Hematology Association (EHA) 2021 Virtual Congress12.5.2021 16:02:34 CEST | Pressemelding

Pressrelease 12 maj 2021 Immunicum håller presentationer vid European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) tillkännagav idag att bolaget kommer att hålla två posterpresentationer gällande sitt lagringsbara återfallsvaccin DCP-001 vid EHA 2021 Virtual Congress, som hålls den 9–17 juni 2021. Sammanfattningarna publiceras på konferensens webbplats och är även tillgängliga via www.ehaweb.org. Presentationerna innehåller interimsresultat från fas II ADVANCE II-studien, som visar DCP-001: s förmåga att inducera immunsvar mot ett brett spektrum av tumörassocierade antigener hos patienter med akut myeloisk leukemi (AML), samt prekliniska resultat av förbättrad effekt vid kombinationen DCP-001 och etablerade AML-behandlingar. "De kliniska interimsresultat som publiceras i sammanfattningen idag gläder oss i och med att vi ser att DCP-001 inducerar en rad detekterbara immunsvar hos AML-patienter som deltar i den pågående ADVANCE II-studien", säger Jeroen

Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress12.5.2021 16:02:34 CEST | Press release

Press Release 12 May 2021 Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) today announced that it will be presenting two posters on its off-the-shelf relapse vaccine DCP-001 at the EHA 2021 Virtual Congress, to be held from June 9-17, 2021. The accepted abstracts are now published on the conference website and accessible through www.ehaweb.org. The presentations include interim immunological results from the Phase II ADVANCE II study, demonstrating DCP-001’s ability to induce immune responses to a broad range of tumor-associated antigens in acute myeloid leukemia (AML) patients, as well as preclinical results of enhanced efficacy when combining DCP-001 with established AML treatment regimens. “From the interim clinical data published in the abstract today, we are excited to see that DCP-001 induces a range of detectable immune responses in AML patients participating in our ongoing ADVANCE II study,” said